Analyst Ratings for Olema Pharmaceuticals
Portfolio Pulse from Benzinga Insights
Over the past 3 months, 8 analysts have published their opinion on Olema Pharmaceuticals (NASDAQ:OLMA) stock. The average price target for the stock has increased by 27.18% from the previous average price target of $17.00 to $21.62. The majority of the analysts are bullish on the stock.
October 11, 2023 | 5:01 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Analysts are bullish on Olema Pharmaceuticals (NASDAQ:OLMA) stock with an average price target of $21.62, indicating a potential upside.
The bullish sentiment from analysts, coupled with an increased average price target, suggests a positive short-term impact on Olema Pharmaceuticals' stock.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100